Digene Gel News Today

Abbott Laboratories Indian unit warns of potential supply shortages of two popular laxative syrups due to production halt in Goa state.

Abbott Laboratories' Indian unit has warned of potential supply shortages of two popular laxative syrups after production was prohibited in India's Goa state, where drug inspectors have found lapses at a company factory, a letter shows. Goa, where Abbott has one of its two India plants, asked the company to halt production of Cremaffin and Duphalac syrups last month. The request followed the recall of another Abbott drug which triggered factory inspections by health officials who fou...

Abbott Laboratories' Indian unit has cautioned about potential shortages of two popular laxative syrups, Cremaffin and Duphalac, due to a production halt in India's Goa state.

Abbott on August 18 had intimated the DCGI office regarding voluntary product recall of all batches of Digene Gel of all flavors (Mint, Orange, mix fruits flavor) which are within the self-life and manufactured at Goa facility

The U.S. based drugmaker is locked in a tussle with drug regulators in the tourist state of Goa in western India after the company, starting August, voluntarily recalled many batches of its Digene Gel syrup produced there after it received customer complaints on taste and odor. Abbott says there is no impact on patient health.

By Rishika Sadam HYDERABAD, India (Reuters) - Indias Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing ...

Earlier this month, regulator DCGI cautioned against the consumption of Digene Gel citing safety concerns even as the drug maker recalled several batches of the medicine manufactured at the Goa facility.

The drug regulatory body also advised doctors and healthcare professionals to carefully prescribe and educate their patients to discontinue the medicines use and for reporting of any adverse drug reactions arising due to consumption of the said product. Goa FDA officials had conducted multiple inspections of the plant after the drug maker announced the recall of the antacid produced at the site.

India's Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing licence of its antacid medicine after inspectors flagged contamination risks and sanitization issues at its factory, government documents show. The U.S. based drugmaker is locked in a tussle with drug regulators in the tourist state of Goa in western India after the company, starting in August, voluntarily recalled many batches of its Digene Gel syrup produced there after it received cu...

Defitalio is used for treatment of a serious condition where vessels in the liver are blocked, and Adcetris is used for the treatment of a type of blood cancer.